+65 63464191 info@healthytimes.com.sg
Health Magazine Singapore l Singapore Health Magazine l Healthy Times Magazine
  • Home
  • Health
  • Fitness
  • Beauty
  • Food & Nutrition
  • Green Living
  • Kids & Women
  • Disease and Prevention
  • Well Being
  • Events
  • Bahasa
Select Page

Indonesia's Kolaka Nickel Advances 20 MW Hybrid Solar-Plus-Storage Project in Southeast Sulawesi

by | PRNewswire Asia

JAKARTA, Indonesia, Sept. 28, 2026 /PRNewswire/ — Indonesia has moved a step closer to greening its nickel industry with the development of a landmark hybrid solar photovoltaic (PV) and battery energy storage system (BESS) project by PT. Kolaka Nickel Indonesia....

CityUHK researchers advance spatial omics to routine clinical use

by | PRNewswire Asia

HONG KONG, Sept. 28, 2026 /PRNewswire/ — Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a tissue, but also where they are located and how they are organised across cells, tissue structures...

Luckin Coffee Celebrates 100 Stores in Singapore

by | PRNewswire Asia

A Milestone in Building a World-Class Coffee Brand SINGAPORE, Sept. 28, 2026 /PRNewswire/ — Luckin Coffee Inc. ("Luckin Coffee", "Luckin" or the "Company") (OTC: LKNCY) today announced the opening of its 100th store in Singapore....

SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients

by | PRNewswire Asia

TOKYO and BOSTON, Sept. 28, 2026 /PRNewswire/ — SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), announced that it has been awarded a grant of...

RIMAN Expands Global Footprint to 22 Markets with Launches Across Europe and Latin America

by | PRNewswire Asia

Expansion into France, Germany, Romania and Ecuador strengthens RIMAN’s growing presence across two key international regions SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ — RIMAN, the global beauty and wellness company redefining K-Beauty through Korean...

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

by | PRNewswire Asia

HONG KONG, Sept. 28, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating...
« Older Entries
Next Entries »
  • Beauty
  • Disease and Prevention
  • Events
  • Fitness
  • Food and Nutrition
  • Green Living
  • Health
  • Kids and Women
  • News
  • Well Being

PRNewswire Asia

Sitemap

Links

editor@healthytimes.com.sg

editor@healthytimes.com.sg (Press Release)

Phone:+65 63464191

  • Facebook
© Copyright healthytimes.com.sg